PEG2000-DMPE

• CAT Number: I041240
• Molecular Formula: C37H72NO11P
• Molecular Weight: 737.90
• Purity: ≥95%
• Synonyms: [(2R)-3-[hydroxy-[2-(2-methoxyethoxycarbonylamino)ethoxy]phosphoryl]oxy-2-tetradecanoyloxypropyl] tetradecanoate
• InChI: InChI=1S/C37H72NO11P/c1-4-6-8-10-12-14-16-18-20-22-24-26-35(39)46-32-34(33-48-50(42,43)47-29-28-38-37(41)45-31-30-44-3)49-36(40)27-25-23-21-19-17-15-13-11-9-7-5-2/h34H,4-33H2,1-3H3,(H,38,41)(H,42,43)/t34-/m1/s1
• InChIKey: SQPXBATXPJRFFE-UUWRZZSWSA-N
• SMILES: CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)OCCOC)OC(=O)CCCCCCCCCCCCC

PEG2000-DMPE (Cat No.:I041240) is a lipid conjugate used in drug delivery systems, particularly in liposome and nanoparticle formulations. The PEG2000 component provides hydrophilic properties, improving the stability, solubility, and circulation time of drug carriers in the bloodstream. DMPE, a lipid moiety, allows the conjugate to integrate into lipid bilayers, enhancing the encapsulation and delivery of therapeutic agents, such as RNA, DNA, or small molecules. PEG2000-DMPE is widely used in targeted drug delivery, gene therapy, and vaccine development, offering improved bioavailability and reduced immune recognition.